Evidence map›Paper›PMID 38031558›Full record

ArticleRegenerative engineering and translational medicine2023

Injectable neural hydrogel as

Nora Hlavac, Deanna Bousalis, Emily Pallack, Yuan Li, Eleana Manousiouthakis, Raffae Ahmad, Christine E Schmidt

Open access · greenAbstract read
In one paragraph

Article in Regenerative engineering and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Delaying Drug Release: A Time Capsule for the Heart.JACC. Basic to translational science · 2025
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nora HlavacBiomedical Engineering, University of Florida, Gainesville, FL, US.
Deanna BousalisBiomedical Engineering, University of Florida, Gainesville, FL, US.
Emily PallackBiomedical Engineering, University of Florida, Gainesville, FL, US.
Yuan LiBiomedical Engineering, University of Florida, Gainesville, FL, US.
Eleana ManousiouthakisBiomedical Engineering, University of Florida, Gainesville, FL, US.
Raffae AhmadBiomedical Engineering, University of Florida, Gainesville, FL, US.
Christine E SchmidtBiomedical Engineering, University of Florida, Gainesville, FL, US.
University of Florida · US

Funding

Combination of Secretome from Electrically Stimulated ASCs and Injectable ECM Scaffolds as Potential SCI TherapyR21NS111398 · NINDS · UNIVERSITY OF FLORIDA · PI SCHMIDT, CHRISTINE E · 2019 to 2019
$419k
NINDS NIH HHS R21 NS111398
6 · The paper itself

Abstract

Purpose: This study demonstrated Methods: Rat-derived iPN hydrogel solutions were combined with a dextran-dye before subcutaneous injection into adult Sprague Dawley rats. After injection, an Results: Gelation of iPN hydrogels was successful upon subcutaneous injection. When combined with iPN, a 10 kDa dextran-dye was reduced to 54% its initial signal at 24 hours, while PLGA-encapsulated dextran-dye in iPN was only reduced to 78% by 24 hours. Modified media stimulation resulted in changes in ASC phenotype and dramatic upregulation of VEGF secretion. The PLGA encapsulation protocol was adapted for use with temperature sensitive biomolecules, however, considerations must be made with loading efficiency for cell secretome as the maximum efficiency was 28%. Conclusion: The results of this study demonstrated successful injection and subsequent gelation of our iPN hydrogel formulation Lay Summary: We developed an injectable decellularized tissue scaffold from rat peripheral nerve tissue (called iPN), a potential minimally invasive therapeutic meant to fill lesion spaces after injury. This study was the first demonstration of iPN delivery to a living animal. The iPN solution was injected subcutaneously in a rat and properly formed a gelled material upon entering the body. Our results showed that encapsulating biomolecules in an FDA-approved polymer (PLGA) slowed the release of biomolecules from the iPN, which could allow therapeutics more time around the scaffold to help repair native tissue. Lastly, we investigated one potential avenue for combining iPN with other regenerative cues obtained from adipose-derived stem cells. Description of Future Works: Future work must focus on optimal loading conditions and release profiles from the iPN hydrogels. Next steps will be applying iPN in various combination therapies for spinal cord injury. We will focus efforts on developing a pro-regenerative secretome that directly promotes neurite extension and neural cell infiltration into iPN scaffolds upon transplantation in spinal cord.

Indexed as

ASCsdecellularized tissueHydrogelinjectablePLGAsecretomespinal cord injury

Identifiers

PMID38031558
PMCPMC10683944
OpenAlexW4318163007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.